Lijia Lixian (立加利仙)立加利仙
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
批准文号:NMPA approval number: 国药准字J20090012
生产企业Manufacturer
- (德国)Chinese legal name: (德国)
主要成分Active Ingredients
- 苯溴马隆片Benxiu Malong Pian
药物知识说明
国药准字J20090012是一种在国家药监局注册认定的药品。该药品含有苯溴马隆片-d7947cd7等成分。
该药品关联的活性成分包括：苯溴马隆片Benxiu Malong Pian。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：(德国)Chinese legal name: (德国)。
您可以探索含有相同成分的其他药品：苯溴马隆片-d7947cd7成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 立加利仙) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 苯溴马隆片Benxiu Malong Pian.
Manufacturers recorded for this product: (德国)Chinese legal name: (德国).
Explore other medicines containing the same ingredient: 苯溴马隆片 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 立加利仙Recorded Chinese name: 立加利仙
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 50mg*10s50 mg × 10s
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- (德国)Chinese legal name: (德国)
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字J20090012
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字J20090012
Manufacturer
Chinese legal name: (德国)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字J20090012
生产企业
(德国)
适应症
本品原发性高尿酸血症、以及通风性关节炎间歇期。
用法用量
1.成人每次口服50mg（1片），每日一次，早餐后服用。 2.用药1～3周检查血清尿酸浓度，在后续治疗中，成人和14岁以上的年轻人每日50～100mg（1～2片），或遵医嘱。
不良反应
1.胃肠反应：恶心及腹部不适等。
2.引起肾结石和肾绞痛。
3.诱发关节炎急性发作。
4.罕见发热、皮疹和肝或肾功能损害。
禁忌
1.对本品中任何成分过敏者。
2.中至重度肾功能损害者（肾小球滤过率低于20ml/min）及患有肾结石的患者。
3.孕妇、有可能怀孕妇女以及哺乳期妇女禁用。
注意事项
1.不能在痛风急性发作期服用，因为开始治疗阶段，随着组织中尿酸溶出，有可能加重病症。
2.为了避免治疗初期痛风急性发作，建议在给药最初几天合用秋水仙碱或抗炎药。
3.治疗期间需大量饮水以增加尿量（治疗初期饮水量不得少于1.5―2升).以免在排泄的尿中由于尿酸过多导致尿酸结晶。定期测量尿液的酸碱度，为促进尿液碱化，可酌情给予碳酸氢钠或枸橼酸合剂，并注意酸碱平衡。病人尿液的pH应调节在6.5―6.8之间。
4.在开始治疗时有大量尿酸随尿排出，因此在此时的用药量要小（起始剂量）。
贮藏
密封，置阴凉处保存。
规格
50mg*10s
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.